Deleterious Changes In Cardiovascular Risk Factors Following Initiation Of Dual Oral Glucose-Lowering Therapy In Clinical Practice

Jun-12

Cardiovascular Endocrinology Pharmacoepidemiology

AUTHORS : Prof Phil McEwan, HEOR, Rhymney House, Unit A Copse Walk, Cardiff Gate Business Park, Cardiff, CF23 8RB – Email: enquiries@heor.co.uk – Profile: https://heor.co.uk/about-us/meet-the-team/phil-mcewan/

JOURNAL : Diabetes

REFERENCE: 61(S1):A311

DOI : 10.2337/db12-836-1328

Read more

More publications

Apr-25

Comparative effect of aspirin versus clopidogrel monotherapy on incident type 2 diabetes in patients with atherosclerotic cardiovascular diseases: A target trial emulation study

Diabetes Pharmacoepidemiology

Read more

Feb-25

Postoperative Weight Loss After Antiobesity Medications and Revision Risk After Joint Replacement

Pharmacoepidemiology Rheumatology

Read more

Feb-25

Comparative effectiveness and prescribing trends of modified release versus immediate release indapamide in patients with hypertension: cohort study

Pharmacoepidemiology Rheumatology

Read more